Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
TaqMan Express Plates

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 25 October 1996:
Vol. 274. no. 5287, pp. 533 - 534
DOI: 10.1126/science.274.5287.533
Prev | Table of Contents | Next

Policy Forums

David R. Bentley

The author endorses the early release into the public domain of all genomic sequence data produced by sequencing centers. Such informal prerelease of data before the finishing stage would have many advantages for both research and commercial exploitation. The data would be of sufficiently high quality to be useful in biological and genetic studies, and restrictions on their early release would impede scientific progress. Free release of raw genomic sequence would lead to unimpeded competition among academic and commercial interests to create new therapeutic agents.

The author is at the Sanger Centre, Wellcome Trust Genome Campus, Hinxton Hall, Hinxton, Cambridge CB10 1SA, UK.

Volume 274, Number 5287, Issue of 25 October 1996, pp. 533-534
©1996 by The American Association for the Advancement of Science.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
New Goals for the U.S. Human Genome Project: 1998-2003.
F. S. Collins, A. Patrinos, E. Jordan, A. Chakravarti, R. Gesteland, L. Walters, and the members of the DOE and NIH planning groups (1998)
Science 282, 682-689
   Abstract »    Full Text »
WebWise: Navigating the Human Genome Project.
K. D. Pruitt (1997)
Genome Res. 7, 1038-1039
   Full Text »    PDF »
.
(1997)
Genome Res. 7, 952-955
   Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)